A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN9035 in Healthy Adult Volunteers and Mildly Hypertensive Participants

NCT05291546 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: REGN9035
DRUG: REGN5381
OTHER: Placebo

Sponsor

Regeneron Pharmaceuticals